Our client had a number of new and emerging products in immuno-oncology. The therapy area is very complex and our client wanted to ensure that medical and commercial teams had an in-depth understanding of the science, data and key issues in immuno-oncology to enable them to interact credibly with healthcare professionals in a variety of different settings. In addition, the rapidly evolving external environment and expedited launch timelines emphasised the need for flexibility to respond to internal reprioritisation.


Immuno-oncology provides an alternative treatment option for oncologists. However, the mechanism of action (MoA) and management of side effects are very different to that of traditional treatment options. Therefore, it is important to ensure that there are adequate educational resources for use by internal teams.


We worked with our client to develop a number of learning curricula. The eLearning modules were built around the patient journey to ensure that the person with the illness was at the core of the communications. Our first step was to identify the baseline knowledge and learning needs of individuals. We then developed a number of curricula that would appeal to different learning styles. These included curricula concerning basic science to help the teams understand the complex MoA and foundation-level curricula around the disease, tumour type and product. The curricula were developed so they could be adapted for both medical and commercial teams to ensure that different learning needs could be met using the most relevant channel for the learner in a cost-effective manner. The initiative was a huge success, and during the first week of the launch, the foundation curricula were completed by >200 users.